CIK 0001833214
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 853899721
- Phone
- +1 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- 4 Open-market buy Director bought 13,000 shares at $10.07 ($130,910)
- 4 Open-market buy Director bought 1,000 shares at $10.09 ($10,090)
- 4 Open-market buy CEO and CFO bought 417,200 shares at $10.00 ($4,172,000)
- 4 Open-market buy Director bought 417,200 shares at $10.00 ($4,172,000)
- 4 Open-market buy CEO and CFO bought 417,200 shares at $10.00 ($4,172,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 8 of 8 · 151 filings